All trials - page: 296

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT04323449Evaluation of Vision-Guided Shared Control for Assistive Robotics ManipulatorsVA Office of Research and Development
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≥ 0 hours
  • use a power wheelchair as primary means of mobility.
  • have difficulties performing everyday tasks (e.g., reaching for water glass, picking up a toothbrush)
  • NOT have impaired vision
  • NOT have pressure ulcers that prevent sitting for extended periods of time
Ended19NATechnologyArm/hand function13 April 202226 March 20201
NCT04309448Augmenting Reactive Stepping With FES After SCIUniversity Health Network, Toronto
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS C, D
  • ≥ 1 years
  • be able to stand independently for 60 seconds.
  • be able to understand English.
  • NOT have implanted device, e.g. pacemaker
Ended2NATechnologyStanding/walking/mobility01 September 201916 March 20201
NCT04307303Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord InjurySalisbury NHS Foundation Trust
  • Age ≥ 18 yrs
  • Level C1-T11
  • AIS A, B, C, D
  • ≥ 1 years
  • NOT have a history of organic bowel obstruction or inflammatory bowel disease
  • NOT have implanted device, e.g. pacemaker
Ended36NATechnologyBowel health07 July 202113 March 20201
NCT04302259Intelligent Spine Interface, Clinical (ISI-C)Rhode Island Hospital
  • Age 18 - 65 yrs
  • Level C7-T10
  • AIS A, B
  • 1 years - 65 years
  • NOT have implanted drug pump or pacemaker device
Active3NATechnologyStanding/walking/mobility01 September 202110 March 20201
NCT04295538Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)AbbVie
  • Age 18 - 70 yrs
  • Level C4-C7
  • AIS A, B
  • ≤ 24 hours
Active60PHASE2DrugArm/hand function06 September 202004 March 202062
NCT04292717Deficit-specific Training in Spinal DisordersUniversity of Zurich
  • Age 18 - 80 yrs
  • Level C1-T12
  • AIS C, D
  • ≥ 6 months
  • NOT have history of cardiac or pulmonary condition
  • be able to walk without assistance on treadmill and 10m over ground
Ended63NARehabilitationStanding/walking/mobility01 January 202103 March 20201